The Role of p53 in Metabolic Regulation
Open accessThe DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
The metabolic changes that occur in a cancer cell have been studied for a few decades, but our appreciation of the complexity and importance of those changes is now being realized. The metabolic switch from oxidative phosphorylation to aerobic glycolysis provides intermediates for cell growth and division and is regulated by both oncogenes and tumor suppressor genes. The p53 tumor suppressor gene has long been shown to play key roles in responding to DNA damage, hypoxia, and oncogenic activation. However, now p53 has added the ability to mediate metabolic changes in cells through the regulation of energy metabolism and oxidative stress to its repertoire of activities. It is therefore the focus of this review to discuss the metabolic pathways regulated by p53 and their cooperation in controlling cancer cell metabolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition to stopping senescent cell proliferation, p53 and RB mediate senescence-related metabolic changes by balancing their effects on glycolysis: p53 restricts the glycolysis activity of senescent cells through several mechanisms [226], while RB upregulates glycolytic genes, resulting in high glycolytic activity [227].”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [226]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Ide, T., Brown-Endres, L., Chu, K., Ongusaha, P. P., Ohtsuka, T., El-Deiry, W. S., Aaronson, S. A., & Lee, S. W. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.09.031 · Cited by 92
RetractedOxidative stress, inflammation, and cancer: How are they linked?
Reuter, S., Gupta, S. C., Chaturvedi, M. M., & Aggarwal, B. B. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.09.006 · Cited by 5,441 · cited 1×
“, superoxide dismutase [SOD], glutathione peroxidase [GPx], and GSH) through protective mechanisms.(39) Even though ROS products are part of normal cellular metabolism produced mainly through the mitochondrial respiratory chain and play roles in cell proliferation and survival signaling Figure 2.”
BackgroundThe Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088 · cited 2×
“In cancer cells, AKT activation is also sufficient to drive glycolysis and lactate production and to suppress macromolecular degradation.(31) AMPK is a heterotrimeric protein consisting of 3 subunits—α, β, and γ—and drives the catabolic, energyproducing responses (i.”
BackgroundOn Respiratory Impairment in Cancer Cells
Warburg, O. (1956) · Science · doi:10.1126/science.124.3215.269 · Cited by 3,468
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820 · cited 1×
“Pyruvate kinase–M2 (PK-M2) is the embryonic splice variant of the rate-limiting enzyme for pyruvate generation that is preferentially expressed in tumor cells and regulates the flux of carbon into ribose-5-phosphate and nucleotide synthesis via phosphotyrosine signaling.(5) Since PK-M2 can regulate the amounts of pyru…”
BackgroundA model for p53-induced apoptosis
Polyak, K., Xia, Y., Zweier, J. L., Kinzler, K. W., & Vogelstein, B. (1997) · Nature · doi:10.1038/38525 · Cited by 2,500
TIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis
Bensaad, K., Tsuruta, A., Selak, M. A., Vidal, M. N. C., Nakano, K., Bartrons, R., Gottlieb, E., & Vousden, K. H. (2006) · Cell · doi:10.1016/j.cell.2006.05.036 · Cited by 2,019 · cited 1×
“The p53 protein induces the transcription of the TIGAR gene, which lowers the intracellular concentrations of fructose-2,6-bisphosphate and thus decreases glycolysis and overall levels of intracellular reactive oxygen species (ROS).(8) The decrease in glycolysis allows for entry into the pentose phosphate pathway (PPP…”
Backgroundp53 Has a Direct Apoptogenic Role at the Mitochondria
Mihara, M., Erster, S., Zaika, A., Petrenko, O., Chittenden, T., Pancoska, P., & Moll, U. M. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00050-9 · Cited by 1,777 · cited 1×
“In contrast to the above target gene regulation, p53 can form a complex with the antiapoptotic proteins BCL-X L and PUMA, resulting in cytochrome c release from mitochondria and promotion of mitochondrial outer membrane permeabilization.(14) p53’s role in the regulation of cellular metabolism is complex given the many…”
Backgroundp53 Regulates Mitochondrial Respiration
Matoba, S., Kang, J.-G., Patino, W. D., Wragg, A., Boehm, M., Gavrilova, O., Hurley, P. J., Bunz, F., & Hwang, P. M. (2006) · Science · doi:10.1126/science.1126863 · Cited by 1,650 · cited 2×
“One way p53 balances the usage of the respiratory and glycolytic pathways is through its downstream mediator, SCO2.(13) SCO2 is critical for regulating a major site of oxygen utilization in the cell, the cytochrome c oxidase (COX) complex.”
BackgroundBrugarolas, J., Lei, K., Hurley, R. L., Manning, B. D., Reiling, J. H., Hafen, E., Witters, L. A., Ellisen, L. W., & Kaelin, W. G. (2004) · Genes & Development · doi:10.1101/gad.1256804 · Cited by 1,384 · cited 1×
“REDD1 overexpression can also downregulate S6K phosphorylation in a TSC1/ TSC2-dependent manner.(33,37) Thus, p53 shuts down IGF-1/AKT and mTOR pathways through the negative regulation of IGF-BP3, PTEN, TSC2, AMPK β1, and sestrins 1 and 2 and thus plays a critical role in cell growth and division, nutritional sensing,…”
BackgroundCooperation and Competition in the Evolution of ATP-Producing Pathways
Pfeiffer, T., Schuster, S., & Bonhoeffer, S. (2001) · Science · doi:10.1126/science.1058079 · Cited by 1,354 · cited 1×
“Why glycolysis is the method of choice for cancer cells may seem surprising given that only 2 molecules of ATP per molecule of glucose are produced during glycolysis and 36 molecules of ATP are produced in oxidative phosphorylation.(4) In the case of cancer cells, a switch in the metabolic pathways allows cancer cells…”
Backgroundp53 Target Genes Sestrin1 and Sestrin2 Connect Genotoxic Stress and mTOR Signaling
Budanov, A. V., & Karin, M. (2008) · Cell · doi:10.1016/j.cell.2008.06.028 · Cited by 1,326 · cited 1×
“Furthermore, p53 up-regulates the expression of 2 target genes, sestrin 1 and sestrin 2, both of which activate AMPK, allowing AMPK to phosphorylate TSC2, which stimulates its GTPase activity to negatively regulate Rheb, the protein that activates mTOR complex 1 (mTORC1).(32) mTORC1 can also directly or indirectly dep…”
BackgroundThe coordinate regulation of the p53 and mTOR pathways in cells
Feng, Z., Zhang, H., Levine, A. J., & Jin, S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502857102 · Cited by 1,235 · cited 1×
“p53 also directly up-regulates TSC2 levels, which also have a negative impact on mTOR activity.(34,35) Furthermore, p53 up-regulates the expression of 2 target genes, sestrin 1 and sestrin 2, both of which activate AMPK, allowing AMPK to phosphorylate TSC2, which stimulates its GTPase activity to negatively regulate R…”
BackgroundTumor suppressors and cell metabolism: a recipe for cancer growth
Jones, R. G., & Thompson, C. B. (2009) · Genes & Development · doi:10.1101/gad.1756509 · Cited by 1,085 · cited 1×
“They allow for cells to undergo metabolic transformation by increasing the expression of nutrient transporters along its surface, thus increasing the uptake of glucose and amino acids, as well as enhancing the biosynthesis of macromolecules, AKTdependent activation of hexokinase and phosphofructokinase, enhanced trans…”
BackgroundVousden, K. H., & Ryan, K. M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2715 · Cited by 959 · cited 3×
“So what determines if p53 will take the antioxidant or pro-oxidant path might depend on the strength or duration of the stress.(3) The pro-oxidant functions of p53 might go into effect when the stress is mild and not persistent and thus allow the cell to repair any damage, allowing the cell to survive.”
BackgroundInfluentialBuzzai, M., Jones, R. G., Amaravadi, R. K., Lum, J. J., DeBerardinis, R. J., Zhao, F., Viollet, B., & Thompson, C. B. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4447 · Cited by 923 · cited 1×
“Treatment of p53 wild-type cells with metformin, a drug proposed to function as an indirect activator of AMPK, has enhanced fatty acid β-oxidation and rate of glycolysis in a p53-dependent manner.(27) Metabolic stress also stimulates β-oxidation through the carnitine palmitoyltransferase (Cpt1) enzyme, and PI3K and Ak…”
BackgroundRegulation of PTEN Transcription by p53
Stambolic, V., MacPherson, D., Sas, D., Lin, Y., Snow, B., Jang, Y., Benchimol, S., & Mak, T. W. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00323-9 · Cited by 912 · cited 1×
“In addition, a reduction in AKT can lead to an increase in p53, which can activate PTEN expression and amplify this loop.(36) In cancer cells, AKT activation is also sufficient to drive glycolysis and lactate production and to suppress macromolecular degradation.”
BackgroundGlutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function
Hu, W., Zhang, C., Wu, R., Sun, Y., Levine, A., & Feng, Z. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001006107 · Cited by 862 · cited 2×
“Another p53 target gene involved in energy production is glutaminase 2, which converts glutamine to glutamate and can be used to enhance the rate of the TCA cycle and oxidative phosphorylation.(10,15) Upon p53 activation and subsequent glutaminase 2 activation, glutamate and α-ketoglutarate levels rise, as well as mit…”
BackgroundROS and p53: A versatile partnership
Liu, B., Chen, Y., & St. Clair, D. K. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.01.011 · Cited by 830 · cited 1×
“Last, ROS can also regulate p53, resulting in a feedback or feed-forward loop depending on whether p53 increases or decreases ROS levels.(52)”
BackgroundFatty acid synthase, a proficient multifunctional enzyme
Wakil, S. J. (1989) · Biochemistry · doi:10.1021/bi00437a001 · Cited by 820 · cited 1×
“In addition, fatty acid synthase, an enzyme capable of de novo fatty acid synthesis of long-chain fatty acids from acetyl-CoA, malonyl-CoA, and NADPH, is a conserved p53 family target gene.(25,26) p53 has also been linked to β-oxidation, which is the breakdown of fatty acids to generate acetyl-CoA, which then enters t…”
BackgroundRegeneration of peroxiredoxins by p53-regulated sestrins, homologs of bacterial AhpD
Budanov, A. V., Sablina, A. A., Feinstein, E., Koonin, E. V., & Chumakov, P. M. (2004) · Science · doi:10.1126/science.1095569 · Cited by 731
The Tumor Suppressor p53 Down-Regulates Glucose Transporters GLUT1 and GLUT4 Gene Expression
Schwartzenberg-Bar-Yoseph, F., Armoni, M., & Karnieli, E. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-0846 · Cited by 726 · cited 1×
“p53 also regulates the expression of GLUT1 and GLUT4 genes through a repression mechanism.(7) Mutations in the DNA binding domain of p53 abolished the repressive effect on GLUT1 and GLUT4, allowing for increased glucose metabolism and cell energy supply.”
BackgroundSuzuki, S., Tanaka, T., Poyurovsky, M. V., Nagano, H., Mayama, T., Ohkubo, S., Lokshin, M., Hosokawa, H., Nakayama, T., Suzuki, Y., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002459107 · Cited by 705 · cited 1×
“Another p53 target gene involved in energy production is glutaminase 2, which converts glutamine to glutamate and can be used to enhance the rate of the TCA cycle and oxidative phosphorylation.(10,15) Upon p53 activation and subsequent glutaminase 2 activation, glutamate and α-ketoglutarate levels rise, as well as mit…”
BackgroundGlycolytic Enzymes Can Modulate Cellular Life Span
Kondoh, H., Lleonart, M. E., Gil, J., Wang, J., Degan, P., Peters, G., Martinez, D., Carnero, A., & Beach, D. (2005) · Cancer Research · doi:10.1158/0008-5472.177.65.1 · Cited by 647 · cited 1×
“Glycolysis is likewise decreased when p53 decreases PGM expression.(12) Increases in PGM allow for enhanced glycolytic flux and indefinite proliferation, which might occur in some cancers that have a mutant p53.”
BackgroundDirect Interaction between Nrf2 and p21Cip1/WAF1 Upregulates the Nrf2-Mediated Antioxidant Response
Chen, W., Sun, Z., Wang, X.-J., Jiang, T., Huang, Z., Fang, D., & Zhang, D. D. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.04.029 · Cited by 638 · cited 1×
“However, under oxidative stress, p53 stimulates expression of p21, which prevents the binding of KEAP1 to NRF2 and allows for NRF2-mediated antioxidant response.(44) The pro-oxidant functions of p53 involve activation of p53-induced gene 3 (PIG3), proline oxidase, BAX, PUMA, and P66SHC or the inhibition/alteration of…”
Backgroundp53 regulates glucose metabolism through an IKK-NF-κB pathway and inhibits cell transformation
Kawauchi, K., Araki, K., Tobiume, K., & Tanaka, N. (2008) · Nature Cell Biology · doi:10.1038/ncb1724 · Cited by 637 · cited 2×
“Kawauchi et al.(54) showed that p53 can regulate the glycolytic pathway through IKK/NF-κB signaling (Figure 1).”
BackgroundFeng, Z., Hu, W., de Stanchina, E., Teresky, A. K., Jin, S., Lowe, S., & Levine, A. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4149 · Cited by 633 · cited 2×
“AMPK β1 is activated by p53, leading to an increase in AMPK and TSC1-TSC2 activity and to deactivation of the mTOR pathway.(34) p53 also directly up-regulates TSC2 levels, which also have a negative impact on mTOR activity.”
BackgroundCarling, D., Zammit, V. A., & Hardie, D. G. (1987) · FEBS Letters · doi:10.1016/0014-5793(87)80292-2 · Cited by 599 · cited 1×
“In addition, AMPK inhibits fatty acid and cholesterol synthesis by phosphorylating the metabolic enzymes acetyl-CoA carboxylase 1 (ACC1), which carboxylates acetyl-CoA to malonyl-CoA, and HMG-CoA reductase (HMGCR).(29) Thus, it might be that p53-creatine and p53-GAMT function in either tumor suppressor mechanisms or k…”
BackgroundPUMA Couples the Nuclear and Cytoplasmic Proapoptotic Function of p53
Chipuk, J. E., Bouchier-Hayes, L., Kuwana, T., Newmeyer, D. D., & Green, D. R. (2005) · Science · doi:10.1126/science.1114297 · Cited by 546
Zheng, L., Roeder, R. G., & Luo, Y. (2003) · Cell · doi:10.1016/s0092-8674(03)00552-x · Cited by 534 · cited 1×
“OCT1 has also been shown to interact with glycolytic enzymes in the OCA-S complex, which may act as a metabolic sensor.(20) There is also an interesting link between p53, glycolysis, and apoptosis where p53-mediated PUMA expression is suppressed by high glucose after growth factor withdrawal.”
BackgroundRoles of p53, MYC and HIF-1 in regulating glycolysis–the seventh hallmark of cancer
Yeung, S. J., Pan, J., & Lee, M.-H. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8224-x · Cited by 514
Modification of p53 with O-linked N-acetylglucosamine regulates p53 activity and stability
Yang, W. H., Kim, J. E., Nam, H. W., Ju, J. W., Kim, H. S., Kim, Y. S., & Cho, J. W. (2006) · Nature Cell Biology · doi:10.1038/ncb1470 · Cited by 486 · cited 1×
“Addition of O-linked N-acetylglucosamine (O-GlcNAc) to serine 149 of p53 results in an increase in stability, high life, and concentration in the cell.(58) Furthermore, it was shown that IKKβ was constitutively modified at Ser 733 with O-linked β-Nacetylglucosamine (O-GlcNAc) in p53deficient mouse embryonic fibroblast…”
BackgroundEllisen, L. W., Ramsayer, K. D., Johannessen, C. M., Yang, A., Beppu, H., Minda, K., Oliner, J. D., McKeon, F., & Haber, D. A. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00706-2 · Cited by 474 · cited 1×
“REDD1 overexpression can also downregulate S6K phosphorylation in a TSC1/ TSC2-dependent manner.(33,37) Thus, p53 shuts down IGF-1/AKT and mTOR pathways through the negative regulation of IGF-BP3, PTEN, TSC2, AMPK β1, and sestrins 1 and 2 and thus plays a critical role in cell growth and division, nutritional sensing,…”
BackgroundTrinei, M., Giorgio, M., Cicalese, A., Barozzi, S., Ventura, A., Migliaccio, E., Milia, E., Padura, I. M., Raker, V. A., Maccarana, M., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205513 · Cited by 436
Medes, G., Thomas, A. J., & Weinhouse, S. (1953) · PubMed · Cited by 405
p53-Induced Up-Regulation of MnSOD and GPx but not Catalase Increases Oxidative Stress and Apoptosis
Hussain, S. P., Amstad, P., He, P., Robles, A., Lupold, S., Kaneko, I., Ichimiya, M., Sengupta, S., Mechanic, L., Okamura, S., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-2287-2 · Cited by 384
Haltiwanger, R. S., Holt, G. D., & Hart, G. W. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39838-2 · Cited by 370 · cited 1×
“Up to 5% of the glucose flux through the cells goes through the hexosamine biosynthetic pathway toward producing UDPGlcNAc, by the enzyme O-GlcNAc transferase.(56,57) Addition of O-linked N-acetylglucosamine (O-GlcNAc) to serine 149 of p53 results in an increase in stability, high life, and concentration in the cell.”
BackgroundThe regulation of energy metabolism and the IGF-1/mTOR pathways by the p53 protein
Feng, Z., & Levine, A. J. (2010) · Trends in Cell Biology · doi:10.1016/j.tcb.2010.03.004 · Cited by 359 · cited 1×
“Also, many regulatory loops exist to keep these pathways in check and balance a response to cellular stress or a decision to grow and divide.(38)”
Backgroundp53 Suppresses the Nrf2-dependent Transcription of Antioxidant Response Genes
Faraonio, R., Vergara, P., Di Marzo, D., Pierantoni, M. G., Napolitano, M., Russo, T., & Cimino, F. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605707200 · Cited by 349
THE FEEDBACK CONTROL OF SUGAR NUCLEOTIDE BIOSYNTHESIS IN LIVER
Kornfeld, S., Kornfeld, R., Neufeld, E. F., & O'Brien, P. J. (1964) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.52.2.371 · Cited by 313 · cited 1×
“Up to 5% of the glucose flux through the cells goes through the hexosamine biosynthetic pathway toward producing UDPGlcNAc, by the enzyme O-GlcNAc transferase.(56,57) Addition of O-linked N-acetylglucosamine (O-GlcNAc) to serine 149 of p53 results in an increase in stability, high life, and concentration in the cell.”
BackgroundBensaad, K., & Vousden, K. H. (2007) · Trends in Cell Biology · doi:10.1016/j.tcb.2007.04.004 · Cited by 305 · cited 1×
“Furthermore, the difference between basal levels of p53 versus increased levels of p53 during severe or sustained stress might allow for the transcription of different sets of genes as well as tissue-specific contexts.(6) p53 influences metabolic pathways by regulating the levels of a series of gene products that affe…”
BackgroundTranscriptional Activation of the Human Glutathione Peroxidase Promoter by p53
Tan, M., Li, S., Swaroop, M., Guan, K., Oberley, L. W., & Sun, Y. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.17.12061 · Cited by 253
Identification of ALDH4 as a p53-inducible gene and its protective role in cellular stresses
Yoon, K.-A., Nakamura, Y., & Arakawa, H. (2004) · Journal of Human Genetics · doi:10.1007/s10038-003-0122-3 · Cited by 234 · cited 1×
“The pro-oxidant functions of p53 involve activation of p53-induced gene 3 (PIG3), proline oxidase, BAX, PUMA, and P66SHC or the inhibition/alteration of expression of antioxidant genes superoxide dismutase 2 (SOD2), aldehyde dehydrogenase 4 (ALDH4), and glutathione peroxidase 1 (GPX1).(43,45-51) These pro-oxidant gene…”
BackgroundGlucose Catabolism in Cancer Cells
Mathupala, S. P., Heese, C., & Pedersen, P. L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.36.22776 · Cited by 231
DeBerardinis, R. J., Lum, J. J., & Thompson, C. B. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m608372200 · Cited by 221 · cited 1×
“Metabolic stress also stimulates β-oxidation through the carnitine palmitoyltransferase (Cpt1) enzyme, and PI3K and Akt modulate its expression to suppress β-oxidation during anabolic growth.(28) In addition, AMPK inhibits fatty acid and cholesterol synthesis by phosphorylating the metabolic enzymes acetyl-CoA carboxy…”
BackgroundMETABOLISM OF NEOPLASTIC TISSUE
Jedeikin, L. A., & Weinhouse, S. (1955) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)71063-6 · Cited by 207
Loss of p53 enhances catalytic activity of IKKβ through O-linked β-N-acetyl glucosamine modification
Kawauchi, K., Araki, K., Tobiume, K., & Tanaka, N. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813210106 · Cited by 193
Metabolism and proliferation share common regulatory pathways in cancer cells
Fritz, V, & Fajas, L. (2010) · Oncogene · doi:10.1038/onc.2010.182 · Cited by 192 · cited 1×
“, phosphatidylinositol, phosphatidyl serine, or phophatidyl choline) that can regulate various oncogenic pathways such as PI3K/AKT, Ras, or Wnt pathways.(23) In response to genotoxic stress and glucose deprivation, p53 modulates creatine biosynthesis and fatty acid oxidation (FAO) by increasing guanidinoacetate N-meth…”
BackgroundReciprocal down-regulation of p53 and SOD2 gene expression-implication in p53 mediated apoptosis
Drane, P., Bravard, A., Bouvard, V., & May, E. (2001) · Oncogene · doi:10.1038/sj.onc.1204101 · Cited by 180 · cited 1×
“For instance, SOD2, which plays a major role in a cell’s defense against oxidative damage, is repressed at the promoter by p53, and in contrast, overexpression of MnSOD (product of the SOD2 gene) results in a decrease in p53mediated apoptosis and the potential to increase oxidative stress.(45) So what determines if p5…”
Backgroundp53 and NF‐κB: different strategies for responding to stress lead to a functional antagonism
Ak, P., & Levine, A. J. (2010) · The FASEB Journal · doi:10.1096/fj.10-160549 · Cited by 178 · cited 1×
“p53 and NF-κB have several differences in dealing with stress responses.(53) In particular, NF-κB initiates a metabolic pathway that uses glucose at a high rate through aerobic glycolysis and the phosphate pentose shunt.”
BackgroundA pivotal role for p53: balancing aerobic respiration and glycolysis
Ma, W., Sung, H. J., Park, J., Matoba, S., & Hwang, P. M. (2007) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-007-9083-0 · Cited by 160 · cited 1×
“It has been shown that ATP is produced at higher levels using oxidative phosphorylation in HCT116 cells expressing p53 versus similar cells lacking p53.(17) One way p53 balances the usage of the respiratory and glycolytic pathways is through its downstream mediator, SCO2.”
BackgroundThe p53-induced Gene-6 (Proline Oxidase) Mediates Apoptosis through a Calcineurin-dependent Pathway
Rivera, A., & Maxwell, S. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504852200 · Cited by 160
O-GlcNAc Transferase Is in a Functional Complex with Protein Phosphatase 1 Catalytic Subunits
Wells, L., Kreppel, L. K., Comer, F. I., Wadzinski, B. E., & Hart, G. W. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406481200 · Cited by 158 · cited 1×
“Uridine diphosphate N-acetylglucosamine (UDP-GlcNAc), which is used as a substrate for N- and O-linked glycosylation, is a modification similar to phosphorylation but achieves opposite effects in terms of function.(55) Up to 5% of the glucose flux through the cells goes through the hexosamine biosynthetic pathway towa…”
BackgroundTumor Protein 53–Induced Nuclear Protein 1 Is a Major Mediator of p53 Antioxidant Function
Cano, C. E., Gommeaux, J., Pietri, S., Culcasi, M., Garcia, S., Seux, M., Barelier, S., Vasseur, S., Spoto, R. P., Pébusque, M.-J., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2320 · Cited by 151
Liu, Z., Lu, H., Shi, H., Du, Y., Yu, J., Gu, S., Chen, X., Liu, K. J., & Hu, C.-A. A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1754 · Cited by 121
Glucose Metabolism Attenuates p53 and Puma-dependent Cell Death upon Growth Factor Deprivation
Zhao, Y., Coloff, J. L., Ferguson, E. C., Jacobs, S. R., Cui, K., & Rathmell, J. C. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803580200 · Cited by 112 · cited 1×
“There is also an interesting link between p53, glycolysis, and apoptosis where p53-mediated PUMA expression is suppressed by high glucose after growth factor withdrawal.(16) Inhibition of p53 activation and PUMA induction is initiated by glucose metabolism that then promotes an antiapoptotic balance supporting cell su…”
BackgroundOct1 loss of function induces a coordinate metabolic shift that opposes tumorigenicity
Shakya, A., Cooksey, R. C., Cox, J. E., Wang, V. E. H., McClain, D. A., & Tantin, D. R. (2009) · Nature Cell Biology · doi:10.1038/ncb1840 · Cited by 110 · cited 1×
“A transcription factor that potentially could mediate the balance between oxidative and glycolytic metabolism through p53 cooperatively is OCT1 (POU2F1).(19) OCT1 might initiate this”
BackgroundColoff, J. L., Mason, E. F., Altman, B. J., Gerriets, V. A., Liu, T., Nichols, A. N., Zhao, Y., Wofford, J. A., Jacobs, S. R., Ilkayeva, O., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.179101 · Cited by 100 · cited 1×
“Similarly, inhibition of PUMA induction is mediated through activated Akt dependence on glycolysis.(21) In contrast to the above target gene regulation, p53 can form a complex with the antiapoptotic proteins BCL-X L and PUMA, resulting in cytochrome c release from mitochondria and promotion of mitochondrial outer memb…”
BackgroundThe Fatty Acid Synthase Gene is a Conserved p53 Family Target Gene from Worm to Human
D’Erchia, A. M., Tullo, A., Lefkimmiatis, K., Saccone, C., & Sbisà, E. (2006) · Cell Cycle · doi:10.4161/cc.5.7.2622 · Cited by 48
GAMT joins the p53 network: Branching into metabolism
Ide, T., Chu, K., Aaronson, S. A., & Lee, S. W. (2010) · Cell Cycle · doi:10.4161/cc.9.9.11473 · Cited by 26 · cited 2×
“Similarly, increased FAO occurs in the livers of wild-type p53 animals, indicating that p53 might play a role in energy maintenance of the FAO pathway.(24) In addition, fatty acid synthase, an enzyme capable of de novo fatty acid synthesis of long-chain fatty acids from acetyl-CoA, malonyl-CoA, and NADPH, is a conserv…”
Background
Cited by
The Tumor Suppressor p53 Limits Ferroptosis by Blocking DPP4 Activity
Xie, Y., Zhu, S., Song, X., Sun, X., Fan, Y., Liu, J., Zhong, M., Yuan, H., Zhang, L., Billiar, T. R., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.07.055 · Cited by 952
“TP53-mediated metabolic changes that occur in cancer cells have been studied for several decades, but our appreciation of the complexity and importance of those changes is only now being realized (Humpton and Vousden, 2016; Parrales and Iwakuma, 2016; Puzio-Kuter, 2011; Vousden and Ryan, 2009).”
PGC-1 α, Inflammation, and Oxidative Stress: An Integrative View in Metabolism
Rius-Pérez, S., Torres-Cuevas, I., Millán, I., Ortega, Á. L., & Pérez, S. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/1452696 · Cited by 642
“On the other hand, p53 may be repressed transcriptionally by GLUT-1 and GLUT-4 genes in situations such as excess caloric intake that cause reduction of PGC-1α, NRF-1, and Tfam activation [123, 124].”
BackgroundRoberts, D. J., & Miyamoto, S. (2015) · Cell Death & Differentiation · doi:10.1038/cdd.2014.173 · Cited by 504
Mitochondrial Sirtuin 3: New emerging biological function and therapeutic target
Zhang, J., Xiang, H., Liu, J., Chen, Y., He, R.-R., & Liu, B. (2020) · Theranostics · doi:10.7150/thno.45922 · Cited by 503
“The stabilization of p53 further impedes glycolysis via inhibition of the transcription of numerous key glycolytic enzymes [87].”
BackgroundFrom Ancient Pathways to Aging Cells—Connecting Metabolism and Cellular Senescence
Wiley, C. D., & Campisi, J. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.05.010 · Cited by 440
“Beyond establishing the proliferative arrest of senescent cells, p53 also plays an important role in the regulation of glycolysis (Kruiswijk et al., 2015; Puzio-Kuter, 2011).”
Background
Metadata
- Authors
- Puzio-Kuter, A. M.
- Venue
- Genes & Cancer
- Publisher
- SAGE Publications
- Published
- 2011-04-01
- Volume
- 2
- Issue
- 4
- Pages
- 385-391
- ISSN
- 1947-6019 (ISSN-L)
- 1947-6027
- PMC
- PMC3135642
- OpenAlex
- W2147294934
- Cited by
- 273
- References
- 60
- Citations by year
- 2026: 9 · 2025: 11 · 2024: 20 · 2023: 13 · 2022: 23 · 2021: 21 · 2020: 26 · 2019: 21 · 2018: 21 · 2017: 24 · 2016: 17 · 2015: 18 · 2014: 24 · 2013: 9 · 2012: 14
- FWCI
- 5.33
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Genes & Cancer (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- p53, tumor suppressor, cancer metabolism, aerobic glycolysis, oxidative phosphorylation, metabolic reprogramming, energy metabolism, oxidative stress, DNA damage response, hypoxia, oncogenes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.